Longevity

MOTS-c

InjectableEvidence C3x per week

Half-life

0.5hours

Typical vial

10mg

Research amounts

5–10mg

per administration

Common schedule

3x per week

Animal or lab only

Only animal or lab studies exist — no human study has set an amount.

Quick start

MOTS-c at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.

Typical dose: 5–10 mg per administration
How often: 3x per week
Where: Commonly subcutaneous Sites and rotation
Time to steady level: ~3 hours — about five half-lives
Storage: Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details

A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.

Molecular reference data.

Sequence (one-letter)

MRWQEMGYIFYPRKLR

External references

These numbers are a starting point — change any of them.

Amount in the vialmgBacteriostatic water you addmLAmount per drawmgAmount unitDevice

Copy this into your label printer.

Label nameDate you mixed itFormatFor 24 mm tape, or 1" x 2 1/8" die-cut stock such as Dymo 30336.

MOTS-c  10 mg/mL
50 units = 5 mg
Recon 2026-09-18

Published research contexts for MOTS-c describe 5–10 mg per administration. Descriptive only, not a recommendation.

Mitochondrial-derived peptide; PK data is thin.

Evidence is preclinical; circulating amounts are community-derived and no human schedule is established, so no schedule table is shown.

1× is the peak after a single dose.

MOTS-c metabolic literature (Lee et al., 2015)Mitochondrial-derived peptide evidence is largely rodent and cell-based.